UK Medicines and Healthcare products Regulatory Agency Begins Rolling Review of Moderna’s mRNA Vaccine Against COVID-19 (mRNA-1273)

Go back to UK Medicines and Healthcare products Regulatory Agency Begins Rolling Review of Moderna’s mRNA Vaccine Against COVID-19 (mRNA-1273)
Marina Biotech, Inc. (NASDAQ: MRNA) Delayed: 154.04 -4.03 (2.55%)
Previous Close $158.07    52 Week High $0.52 
Open $158.35    52 Week Low $0.08 
Day High $159.79    P/E N/A 
Day Low $150.29    EPS $-3.80 
Volume 20,237,194